Staar warning letter progress
This article was originally published in The Gray Sheet
Executive Summary
Staar Surgical is preparing for facility inspections following FDA's recent pronouncement that the firm's warning letter corrective action plan is "adequate," the company says. The Dec. 22 warning letter stemmed from quality system regulation and device reporting violations discovered during a pre-approval inspection related to Staar's Collamer implantable contact lens (1"The Gray Sheet" Jan. 12, 2004, p. 7). Staar will provide an update on the expected re-inspection timeframe by the end of April. The firm's stock rose 21% March 31 on disclosure of the development...
You may also be interested in...
Staar Warning Letter Presents Challenges For ICL Approval Timeline
Staar Surgical continues to anticipate approval for the Collamer ICL implantable contact lens by April, despite compliance issues raised in a Dec. 22 FDA warning letter
Cochlear’s Osia System Receives Expanded FDA Clearance For Use In Younger Children
Kids ages 5 and up now can benefit from Cochlear’s Osia implant and sound processor, indicated for hearing loss, mixed hearing loss and single-sided sensorineural deafness.
MAISI: Navigating The 'Valley Of Death' In Medtech Research Translation
Translating research from proof of concept to clinical investigations is a difficult hurdle to overcome. To succeed, researchers need to design their technology for industrial standard manufacturing early on, Anne Vanhoestenberghe, director for the Manufacture of Active Implants and Surgical Instruments (MAISI), told Medtech Insight.